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Vascular endothelial activation, marked by de novo expression
of E-selectin, is an early and essential event in the process of
leukocyte extravasation and inflammation. Evidence suggests
that hepatocyte growth factor (HGF) ameliorates inflammation
in animal models of renal disease, implying that HGF might
inhibit specific components of the inflammatory response.
This study examined the effect of HGF on endothelial
E-selectin expression in acute inflammation induced by tumor
necrosis factor (TNF)-a. In vitro, HGF suppressed TNF-a-induced
cell surface expression of E-selectin in human umbilical vein
endothelial cells (HUVEC) and inhibited E-selectin mediated
monocytic adhesion to endothelial monolayers. HGF activated
phosphatidylinositol 3-kinase (PI3K)–Akt that in turn inhibited
its downstream transducer glycogen synthase kinase (GSK)3.
Blockade of the PI3K–Akt pathway with specific inhibitors
abrogated HGF induced inhibitory phosphorylation of GSK3
and suppression of E-selectin. In addition, selective inhibition
of GSK3 activity by lithium suppressed TNF-a-induced
E-selectin expression and monocytic adhesion, reminiscent of
the action of HGF. Moreover, ectopic expression of an
uninhibitable mutant GSK3b, in which the regulatory serine-9
is replaced by alanine, abolished HGF’s suppressive effect on
endothelial E-selectin. In vivo, administration of exogenous
HGF reduced endothelial expression of E-selectin induced by
bolus injection of TNF-a. This was associated with less
sequestration of circulating fluorescence-labeled macrophages
in the kidney. These findings suggest that HGF ameliorates
acute renal inflammation in part by downregulating E-selectin
mediated macrophage adhesion to the inflamed endothelium.
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Inflammation, characterized by tissue infiltration by leuko-
cytes, is a basic biological reaction and part of the innate
defense to injuries induced by various pathogenic factors.1
An inflammatory response of appropriate magnitude and
timing is crucial to tissue repair and homeostasis.1,2 Most
inflammatory responses are acute and self-limiting; however,
an excessive inflammatory reaction may result in critical and
fatal conditions as systemic inflammatory response syn-
drome, severe acute respiratory syndrome, and acute renal
failure. In addition, if the inflammatory response is
prolonged or frequently relapsing chronic persistent inflam-
mation develops, which may promote fibrosis and loss of
organ function.3 Immunosuppressants including glucocorti-
coids are widely used to treat patients with excessive or
chronic inflammation and reduce the likelihood of these
complications, despite an increased risk of opportunistic
infections.1–3
Vascular endothelial activation and dysfunction play a
critical role in the inflammatory response.4–8 Normally,
leukocytes continuously patrol the vasculature, alert for
signals of inflammation. Proinflammatory substances re-
leased by pathogens (e.g. lipopolysaccharide) or by damaged
tissue (e.g. tumor necrosis factor (TNF)-a) upregulate the
expression of adhesion molecules on the endothelium and
initiate the migration of leukocytes to the inflamed area.
Leukocyte migration from blood to tissues involves several
steps: rolling, sticking, diapedesis, and chemotaxis.9 Among
these processes, rolling is the earliest and indispensable event
initiating leukocyte extravasation and inflammation. Rolling
is mediated by the selectin family of adhesion molecules,
endothelial E-selectin, platelet P-selectin, and leukocyte
L-selectin.10 Both E- and P-selectins are expressed by
endothelial cells; L-selectin is found only on leukocytes.
P- and L-selectins are constitutively expressed whereas
E-selectin is elicited by proinflammatory stimulate and
is considered essential for leukocyte trafficking.10 The
importance of E-selectin in initiating inflammation is
demonstrated by the potent anti-inflammatory effect of
E-selectin blockade.11–16
Hepatocyte growth factor (HGF) is a mesenchymal-
derived, pleiotropic multifunctional growth factor.17 Upon
binding to its receptor, c-Met, HGF triggers several signal
transduction pathways, including phosphatidylinositol
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3-kinase (PI3K)–Akt, Ras–Mek–Erk, and Stat3 pathway, and
modulates diverse cell processes including mitogenesis,
motogenesis, morphogenesis, and antiapoptosis/survival in
epithelial and endothelial cells.17,18 Evidence suggests that
HGF ameliorates both acute and chronic injury in various
organs including kidney,19 liver,20 lung,21 and intestine.22 Of
note, inflammation is an invariable finding in both acute and
chronic disease. Inflammation subsides in response to HGF
treatment; however, the potential beneficial effects of HGF on
inflammation have been largely overlooked. Recently, we
reported that HGF treatment substantially attenuated
inflammation in the rat remnant kidney model of chronic
renal failure;23 however, the mechanisms responsible for this
action remain uncertain. In this study, we show that HGF
abrogates monocyte to endothelial adhesion and ameliorates
acute renal inflammation by suppressing endothelial E-
selectin expression. These findings suggest that the beneficial
effects of HGF in both acute and chronic disease may be
partially ascribed to its systemic anti-inflammatory action on
the endothelium.
RESULTS
HGF suppresses TNF-a induced endothelial E-selectin ex-
pression in vitro
As presented in Figure 1a, TNF-a strongly stimulated E-
selectin expression at low doses without significantly
reducing the human umbilical vein endothelial cells (HU-
VEC) viability. Western immunoblot of whole-cell lysates
showed that HGF treatment suppressed TNF-a induced total
E-selectin expression in a time-dependent manner. E-selectin
is found both on the cell membrane and in the intracellular
reservoir in activated endothelial cells.24 Only membrane E-
selectin is accessible to leukocytes and functionally active in
mediating the endothelial–leukocyte adhesion. To examine
whether HGF treatment modulated cell surface expression of
E-selectin, flow cytometry (Figure 1b) and fluorescent
immunocytochemistry (Figure 1c–f) without cell membrane
permeabilization were employed. As shown in Figure 1c–f,
control and HGF alone treated HUVEC cells are negative for
E-selectin. TNF-a markedly induced E-selectin expression
with a typical surface distribution pattern, and HGF
pretreatment significantly decreased the surface E-selectin
staining. Flow cytometry analysis corroborated the immu-
nocytochemistry findings. HGF prevented TNF-a induced
surface expression of E-selectin in HUVEC cells.
HGF blunts TNF-a elicited monocyte to endothelial adhesion
in vitro
To determine whether HGF suppression of endothelial E-
selectin expression reduces leukocyte adhesion to endothe-
lium, we employed the monocytic static adhesion assay.25
Few fluorescent THP-1 cells were found adherent to vehicle
(Figure 2a) or HGF (Figure 2b) treated HUVEC monolayers.
TNF-a promoted monocyte adhesion (Figure 2c), and HGF
strikingly prevented it (Figure 2d). To quantify monocytes
adherent to HUVEC monolayers, cells were lysed and
subjected to fluorometric analysis (Figure 2f), which was in
agreement with the microscopic findings. Of note, addition
of a specific rabbit anti-E-selectin antibody blocked mono-
cyte adhesion, suggesting that E-selectin mediates endothelial
to monocyte adhesion and that suppression of endothelial
expression of E-selectin by HGF accounts for the reduction in
monocytic adhesion.
The PI3K–Akt pathway is required for HGF suppression of E-
selectin
After binding to its cognate receptor, c-Met, HGF triggers
multiple signaling pathways including the PI3K–Akt pathway,
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Figure 1 | HGF suppresses TNF-a induced endothelial E-selectin expression in HUVEC cells. (a) HUVEC cells were pretreated with HGF
(100 ng/ml) or vehicle for 30 min before stimulation of TNF-a (0.1 ng/ml or otherwise as indicated). Cell lysates were harvested at different time
points after TNF-a stimulation and analyzed for E-selectin by Western immunoblot. Actin served as a standard molecule for normalization. (b)
Flow cytometric analysis of cell surface E-selectin in HUVEC cells after 4 h of TNF-a (0.1 ng/ml) stimulation with or without HGF (100 ng/ml)
pretreatment. (c–f) Representative micrographs of fluorescent immunocytochemistry depicted cell surface E-selectin expression on HUVEC cells
pretreated with vehicles (c, e), or 100 ng/ml GF (d, f) before stimulation of 0.1 ng/ml TNF-a (e, f) or vehicle (c, d) for 4 h. Original magnification:
(c–f)  200 and (inset in e)  400.
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Ras–Mek–Erk pathway, and Stat3 pathway.18 HGF activated
all three pathways in HUVEC cells, while TNF-a had only a
minor effect (Figure 3a). To determine which signaling
pathway mediates HGF suppression of E-selectin, we
pretreated HUVEC with various inhibitors specific for each
pathway. As shown in Figure 3b, the suppressive effect of
HGF on TNF-a -induced E-selectin was blocked by two
different inhibitors specific for the PI3K–Akt pathway,
wortmannin and LY294002. In contrast, U0126, the selective
inhibitor for the Ras–Mek–Erk pathway and PpYLKTK-mts,
the Stat3 inhibitor, failed to abolish the HGF’s inhibitory
action (Figure 3c). These data suggest that the PI3K–Akt
pathway mediates HGF’s suppression of E-selectin in
endothelial cells.
HGF inhibits glycogen synthase kinase (GSK) 3 via PI3K–Akt
mediated phosphorylation in endothelial cells
GSK3 is an important downstream transducer of the
PI3K–Akt signaling pathway. GSK3 is inactivated in response
to PI3K signaling, as a result of Akt-mediated phosphoryla-
tion of an N-terminal serine, serine-9 in GSK3b and Ser-21 in
GSK3a.26 Because phosphorylation of GSK3 at these two
residues denotes GSK3 inactivation, we probed using a
specific antibody against phosphorylated GSK3a (S21) and
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Figure 2 | HGF functionally attenuates TNF-a elicited monocyte adhesion to HUVEC monolayers. Representative fluorescent micrographs
show human monocyte adhesion to HUVEC monolayers. HUVEC cells were pretreated with (a, c) vehicle or (b, d) 100 ng/ml HGF before
addition of (c, d) 0.1 ng/ml TNF-a or (a, b) vehicle. After 4 h, Calcein-AM-labeled (green fluorescence) THP-1 cells were applied. Prior to TNF-a
stimulation a rabbit anti-E-selectin antibody (2 mg/ml) or preimmune IgG (2 mg/ml) was given to demonstrate the role of E-selectin in monocyte
adhesion. (e) Nonlabeled THP-1 cells were applied to TNF-a treated HUVEC cells and served as negative controls. (f) Aliquots of cell lysates were
subjected to fluorometric analysis to quantify the amount of adherent monocytes. aE-sel, anti-E-selectin blocking antibody. *Po0.05 vs other
treatments. Original magnification: (a–e)  100.
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Figure 3 | HGF activates c-Met and triggers multiple signaling pathways in endothelial cells, including PI3K–Akt, which is required for
suppression of E-selectin. (a) HUVEC cells were pretreated with HGF (100 ng/ml) for 30 min before TNF-a (0.1 ng/ml) stimulation. At different
time points after TNF-a stimulation, cell lysates were analyzed by immunoblotting for different molecules. (b) Pretreatment for 30 min with
wortmannin (50 nM) and LY294002 (20 mM), specific chemical inhibitors for PI3K, diminished HGF’s suppressive effect on E-selectin expression in
HUVEC cells. (c) Pretreatment with a Stat3 inhibitor (160 mM PpYLKTK-mts, Calbiochem, San Diego, CA, USA), or with U0126 (10 mM) to block the
Mek–Erk pathway, failed to override HGF suppression of E-selectin.
1168 Kidney International (2006) 69, 1166–1174
o r i g i n a l a r t i c l e R Gong et al.: HGF suppresses acute renal inflammation
GSK3b (S9). In HUVEC cells, HGF treatment immediately
elicited inhibitory phosphorylation of GSK3b and, to a lesser
extent, GSK3a (Figure 4a). This effect persisted for at least
90 min in the presence or absence of TNF-a, while TNF-a
alone had only a minor effect. In addition, HGF-induced
inhibitory phosphorylation of GSK3 was abolished by
wortmannin (Figure 4b), implying that activation of
PI3K–Akt pathway is required for this action.
Inhibition of GSK3 mimics HGF suppression of TNF-a induced
E-selectin expression in endothelial cells
To avoid cell loss due to induction of apoptosis, the general
apoptosis inhibitor BOC-Asp-CH2F was added to the
culture.27 At the optimal concentration not associated with
significant apoptosis, lithium (20 mM), a selective inhibitor
for GSK3,28 induced inhibitory phosphorylation of GSK3
(Figure 5a), and attenuated basal and TNF-a-induced
E-selectin in HUVEC (Figure 5b), reminiscent of the action
of HGF. Sodium, an osmolality control, had no effect.
Blockade of PI3K–Akt–GSK3 pathway by specific chemical
inhibitors functionally inhibits endothelial to monocyte
adhesion
The finding that activation of PI3K–Akt and subsequent
inhibition of GSK3 mediates HGF suppression of E-selectin
prompted us to investigate whether the PI3K–Akt–GSK3
cascade regulates endothelial to monocyte adhesion. HUVEC
monolayers were activated with TNF-a and subjected to static
adhesion assay after pretreatment with HGF or different
selective chemical inhibitors of the PI3K–Akt–GSK3 pathway.
Fluorometric analysis of cell lysates demonstrated that
inhibition of GSK3 by lithium attenuates TNF-a-induced
endothelial to monocyte adhesion, similar to the effect of
HGF. Sodium, the osmolality control, had no effect. Blockade
of PI3K activation by wortmannin also blocked the inhibitory
action of HGF on monocytic adhesion from 4 h on (Figure 6).
Ectopic expression of uninhibitable mutant GSK3b abolishes
HGF inhibition of endothelial E-selectin in vitro
GSK3 consists of two distinct isoforms, GSK3a and GSK3b.
Previous studies suggested that GSK3b, but not GSK3a, is
essential for TNF-a or IL-1b-induced inflammatory re-
sponses.29 To further examine the role of inhibitory
phosphorylation of GSK3b in HGF inhibition of E-selectin,
we studied the effect of forced expression of GSK3b on E-
selectin in HUVEC cells. Vectors encoding the hemagglutin
(HA) tagged wild type (WT) GSK3b or uninhibitable mutant
GSK3b,30 in which the regulatory serine-9 residue was
replaced by alanine (S9A-GSK3b), were transfected into
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Figure 4 | HGF induces GSK3 inhibition through PI3K–Akt-
dependent phosphorylation in endothelial cells. (a) HUVEC cells
were pretreated with HGF (100 ng/ml) for 30 min, and/or then
stimulated with TNF-a (0.1 ng/ml) for different intervals before cell
lysates were harvested for immunoblot analysis of different
molecules. (b) Pretreatment for 30 min with wortmannin (50 nM)
diminished HGF activation of PI3K–Akt–GSK3 pathway assessed by
phosphorylation of Akt and GSK3.
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Figure 5 | Specific inhibition of GSK3 by lithium (LiCl) mimics HGF
suppression of TNF-a induced E-selectin expression in endothe-
lial cells. (a) LiCl (20 mM) induced inhibitory phosphorylation in
HUVEC cells. As an osmolality control, sodium chloride (20 mM) had
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Figure 6 | Blockade of the PI3K–Akt–GSK3 pathway by specific
chemical inhibitors functionally impedes endothelial to mono-
cyte adhesion. HUVEC monolayers were pretreated with LiCl
(20 mM), NaCl (20 mM), HGF (100 ng/ml), wortmannin (50 nM), or
vehicle before addition of TNF-a (0.1 ng/ml). At different time
intervals, Calcein-AM labeled THP-1 cells were applied for monocyte
adhesion assay as described in the Materials and Methods. Aliquots of
cell lysates were subjected to fluorometric analysis to measure the
quantity of adherent monocytes. Values are expressed as mean
relative inhibition over HUVEC monolayers pretreated with vehi-
cle7s.d. from three separate experiments. *Po0.05 vs HGF treatment
at the same time points.
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HUVEC cells. As a control, pcDNA3 was used in transfection.
To evaluate the levels of expression, whole-cell lysates were
analyzed by immunoblotting for HA or HA-GSK3b (Figure
7a). Immunofluorescent detection using an antibody against
the HA epitope revealed that over 50% of the cells expressed
the HA-tagged constructs 24 h after transfection. As shown in
Figure 7a–c, HGF inhibition of TNF-a induced E-selectin
expression was evident in HUVEC cells transfected with
pcDNA3 or WT-GSK3b. In contrast, ectopic expression of
S9A-GSK3b abolished the suppressive action of HGF on E-
selectin expression. Collectively, these findings suggest that
inhibitory phosphorylation of GSK3b at serine-9 is required
for HGF inhibition of E-selectin in HUVEC cells.
HGF suppresses TNF-a provoked endothelial E-selectin
expression in vivo
The behavior of endothelial cells in vivo may differ from
HUVEC cells in culture. To examine the effect of HGF on E-
selectin expression in acute inflammation in vivo, rats were
given a bolus intra-arterial injection of TNF-a. After 4 h,
fluorescent immunohistochemistry revealed abundant stain-
ing for E-selectin in the kidney (Figure 8c) that was
distributed in the pattern of the interstitial microvasculature
(Figure 8e). HGF treatment reduced E-selectin staining
(Figure 8d). The quantitative fluorescence intensity of E-
selectin (Figure 8f) was significantly weakened in kidneys
from HGF treated group. Western immunoblot analysis of
total kidney homogenates confirmed that HGF prevented
TNF-a induced E-selectin expression (Figure 8g).
HGF protects against acute renal inflammation via suppres-
sion of E-selectin
To confirm the functional significance of HGF suppression of
E-selectin in the kidney, fluorescent viable rat alveolar
macrophages (RAM) were infused into the carotid artery
after administration of HGF and/or TNF-a as described in
Materials and Methods. Tissues were processed for fluor-
escent histological analysis after 30 min. As shown in Figure
9c, many fluorescent RAM cells were found in the kidneys in
TNF-a treated animals, most prominently in the interstitium
of juxtamedullary cortex. An anti-E-selectin blocking anti-
body (figure not shown) or HGF (Figure 9d) markedly
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Figure 8 | HGF suppresses TNF-a provoked endothelial E-selectin expression in rats. (a–e) Representative microphotographs of fluorecent
immunohistochemistry show the expression of E-selectin in rats receiving an arterial injection of (c–e) TNF-a (2 mg/kg) or (a, b) vehicle after
pretreatment of (b, d) HGF (100 mg/kg) or (a, c, e) vehicle for 30 min. After 4 h, kidney sections were snap frozen and processed for
immunofluorescent staining of E-selectin. Tissues were counterstained with 40,6-diamidino-2-phenylindole and Evans’ blue. Original
magnification (a–d)  200 and (e)  400. (f) Relative fluorescent intensity of E-selectin as estimated by quantitative immunofluorescence
analysis; *Po0.01 vs other groups (n¼ 3). (g) Representative pictures of Western immunoblot analysis of E-selectin expression in kidney
homogenates.
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Figure 7 | Forced expression of the uninhabitable mutant GSK3b
abolishes HGF inhibition of endothelial E-selectin in HUVEC cells.
HUVEC were transfected by electroporation with the empty vector
pcDNA3 or vectors encoding the HA-tagged wild type (WT) or the
uninhibitable mutant (S9A). (a) At 24 h after transfection, cells were
stimulated with TNF-a (0.1 ng/ml) after HGF (100 ng/ml) pretreat-
ment. Cell lysates were subjected to Western immunoblot anslysis.
(b) Fluorescent immunocytochemistry staining shows expression of
HA tag in the transfected cells (Original magnification: 200). (c)
Relative inhibition of E-selectin by HGF was estimated by densito-
metric analysis of the immunoblot bands as shown in (a). *Po0.01 vs
cells transfected with pcDNA3 or WT (n¼ 3).
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decreased the number of RAM cells. Quantification of RAM
cells by fluorometric analysis of kidney homogenates (Figure
9e) was in agreement with the morphologic findings.
DISCUSSION
Inflammation is a common finding in both acute and chronic
injuries of diverse etiologies. Leukocyte to endothelium
adhesion mediated by the selectin family of adhesion
molecules, in particular E-selectin, is an indispensable event
initiating the inflammatory reaction.6–10 In the present study,
we found that HGF suppresses monocyte to endothelial
adhesion and attenuates acute renal inflammation via
inhibition of endothelial E-selectin expression. HGF exerts
this action via activation of PI3K–Akt–GSK3b pathway in
endothelial cells. This finding complements our recent report
demonstrating that HGF attenuates renal inflammation in
the rat remnant kidney model of chronic renal disease.23
HGF has also recently been reported to be anti-inflammatory
in non-renal diseases.21,31–34 In a murine model of inflam-
matory bowl disease (IBD), HGF gene transfection dimin-
ished inflammatory infiltrates in the intestinal epithelium.31
Similarly, Arthur et al.32,33 reported that direct intravenous
infusion of exogenous HGF to rats with IBD significantly
ameliorated gross and microscopic bowl inflammation. In a
murine model of airway hyperresponsiveness, airway inflam-
mation was reduced by administration of recombinant
HGF.34 In the present study, exogenous HGF significantly
attenuated TNF-a induced macrophage infiltration and acute
renal inflammation in rats. The finding that HGF has
systemic anti-inflammatory effects suggests that HGF may
intercept common processes in the general inflammatory
reaction rather than organ-specific mechanisms.
Leukocyte adhesion to an activated endothelium is a
prerequisite for generating an inflammatory infiltrate and is
found in virtually all-inflammatory diseases.8,9 Increased
expression of particular adhesion molecules is an important
early marker of endothelial activation. E-selectin is of
particular interest because it is only found on the inflamed
endothelium in contrast to other adhesion molecules, which
have a wide constitutive tissue distribution.9 Previous studies
demonstrated that inhibition of endothelial activation by
glucocorticoids35 or statins36 attenuates inflammation by
decreasing endothelial expression of adhesion molecules,
including E-selectin. Similarly, blocking the interaction
between the endothelium and leukocytes with E-selectin
antibodies as well as selectin antagonists also ameliorates
various inflammatory diseases.11–16 For instance, anti-E-
selectin blocking antibody or E-selectin gene disruption
protected mice from ischemia–reperfusion induced acute
renal failure.12 Similarly, antibody blockade of E-selectin
decreased adventitial inflammation and attenuated intimal
hyperplasia in rat carotid arteries after balloon injury.13
Moreover, transgenic mice producing soluble E-selectin that
can competitively inhibit the binding of inflammatory cells to
E-selectins on the endothelium are resistant to bleomycin
induced chronic pulmonary inflammation and lung fibro-
sis.14 All these studies suggest the therapeutic potential of E-
selectin blockade in inflammatory diseases. In our study,
HGF was found to suppress endothelial E-selectin expression
in cultured HUVEC cells and in vivo in rats injected with
TNF-a. Suppression of E-selectin in turn was responsible, at
least in part, for HGF-induced suppression of monocyte to
endothelial adhesion and inflammation in the kidney.
The mechanism by which HGF regulates endothelial E-
selectin expression is not well studied. The PI3K–Akt pathway
is a major signaling cascade triggered by the binding of HGF
to its cognate receptor c-Met on endothelial cells.17–19 In the
present study, HGF activated PI3K–Akt in endothelial cells
and specific blockade of PI3K–Akt overrode HGF suppression
of E-selectin expression. These data are consistent with
another study in a murine model of endotoxemia,37 in which
blocking the PI3K–Akt pathway with wortmannin or
LY294002 enhanced LPS-induced E-selectin levels and
exacerbated macrophage infiltration in liver and kidney.
GSK3 is an important downstream substrate of the PI3K–Akt
signaling pathway that has been shown to regulate the
inflammatory response.29,38 A ubiquitously expressed serine-
threonine kinase, GSK3 exists in two isoforms, GSK3a and
GSK3b and is a unique signal transducer in that it is
constitutively active under normal conditions. GSK3 is
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Figure 9 | HGF decreases renal sequestration of macrophages, predominantly located in the interstitium of juxtamedullary cortex,
after TNF-a stimulation. (a–d) Representative fluorescent micrographs depict renal sequestration of Calcein-AM labeled (green fluorescent)
RAM cells in rats receiving an arterial injection of (c, d) TNF-a (2 mg/kg) or (a, b) vehicle after pretreatment of (b, d) HGF (100 mg/kg) or (a, c)
vehicle for 30 min. After 4 h, Calcein-AM labeled RAM cells were infused. Kidneys were harvested after 30 min and processed for fluorescent
histological examination. Prior to TNF-a injection, a rabbit anti-E-selectin antibody or preimmune IgG was given to demonstrate the role of E-
selectin in inflammation. Tissues were double counterstained with 40,6-diamidino-2-phenylindole and Evans’ blue. (a–d) Original magnification
 200. (e) Aliquots of kidney homogenates from differently treated groups were subjected to fluorometry to quantify the sequestrated RAM
cells. aE-sel, anti-E-selectin blocking antibody. *Po0.05 vs other groups (n¼ 4).
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inactivated in response to PI3K signaling, as a result of Akt-
mediated inhibitory phosphorylation.39,40 We found that
HGF induced inhibitory phosphorylation of both GSK3a and
GSK3b in endothelial cells. Selective inhibition of GSK3 by
lithium also inhibited phosphorylation of GSK3 and
suppressed TNF-a-induced E-selectin expression in HUVEC
cells, reminiscent of the action of HGF. Furthermore, ectopic
expression of a mutant construct encoding the uninhibitable
GSK3b blunted HGF-induced suppression of E-selectin,
again suggesting that HGF inhibits E-selectin via inhibition
of GSK3b. A regulatory role for GSK3b in E-selectin gene
expression was also reported by Hoeflich et al.29 In that study,
E-selectin-luciferase transcription induced by TNF-a or IL-1b
was reduced in GSK3b/ cells and could be restored by the
expression of exogenous GSK-3.
The mechanism by which GSK3b inactivation modulates
E-selectin is unclear. Recent data suggest that GSK3b is an
essential element for NF-kB activation.41–43 Sequence analysis
reveals the presence of multiple putative kB elements in the
promoter region of the E-selectin gene.44 In addition,
interaction between NF-kB and kB elements in the E-selectin
promoter is required for E-selectin expression.44,45 Therefore,
it is possible that HGF inhibition of endothelial E-selectin
and inflammation might be due to suppression of NF-kB via
GSK3b inactivation. GSK3b has been recently suggested to be
a key regulator of multiple cellular processes implicated in
the pathogenesis of diabetes and chronic inflammatory
diseases.26,38 Due to its regulatory effect on GSK3b, HGF
might represent a novel potential strategy for the treatment
of inflammatory diseases.
In summary, HGF suppresses E-selectin expression in the
activated endothelium and thereby attenuates monocyte to
endothelial adhesion and alleviates acute inflammation in the
kidney. Our findings suggest that HGF might exert its
beneficial effects in various disease models at least in part
through its potent anti-inflammatory action on vascular
endothelium.
MATERIALS AND METHODS
Cell culture
HUVEC were purchased from VEC Technologies (Rensselaer, NY,
USA) and maintained in MCDB-131 complete media. HUVEC cells
(2–8 passages) were seeded on gelatin (1.5%) coated cultures at
approximately 80% confluence. After growth for 24 h in complete
media, cells underwent serum starvation for 6 h in Medium 199.
Human recombinant HGF (Genentech, South San Francisco, CA,
USA) and human recombinant TNF-a (R&D systems, Minneapolis,
MN, USA) were added to the culture with fresh serum-free medium
at a final concentration of 100 and 0.1 ng/ml respectively, or as
otherwise indicated. In experiments with GSK3 blockade, the
general apoptosis inhibitor BOC-Asp-CH2F (Enzyme Systems
Products, Dublin, CA, USA) was added to the culture at the final
concentration of 50 mM to reduce cell loss due to induction of
apoptosis.27 Cell viability was assessed by Trypan blue exclusion.
Human monocytes (THP-1) and RAM were purchased from
American Type Culture Collection (ATCC, Manassas, VA, USA)
and were cultured in suspension respectively in RPMI supplemented
with 10% fetal bovine serum and Ham’s F12K containing 15% fetal
bovine serum. For fluorescent viable labeling, THP-1 and RAM cells
(1 107) were incubated in their respective media containing 5 mg/
ml Calcein-AM (Molecular Probes, Eugene, OR, USA) at 371C for
30 min. Excess dye was removed by washing three times with
phosphate-buffered saline.
Monocytic adhesion assay
Adhesion studies were performed with the THP-1 cells under static
conditions.25 Briefly, HUVEC monolayers with equal cell numbers
in 12-well plates were treated with HGF and/or TNF-a for 4 h. After
addition of 1 ml fluorescence-labeled THP-1 cells (1 106 cells/ml)
per well, the plates were incubated for 30 min at 371C. Monolayers
were gently washed three times with phosphate-buffered saline after
incubation. Adherent monocytes were lysed with RIPA buffer23 and
fluorescent intensity was measured in a Spectramax GEMINI EM
fluorescence plate reader (Molecular Devices, Sunnyvale, CA, USA)
at an excitation wavelength of 485 nm and emission at 530 nm.
HUVEC monolayers adhered with non-labeled THP-1 cells served as
negative controls.
Transient transfection
The expression vectors encoding the HA-tagged wild-type (WT-
GSK3b-HA/pcDNA3) and uninhibitable mutant GSK3b (S9A-
GSK3b-HA/pcDNA3) were kindly and respectively provided by Dr
Jim Woodgett (University of Toronto, Totonto, Ontario, Canada)46
and Dr Gail VW Johnson (University of Alabama at Birmingham,
Birmingham, AL, USA).30 HUVEC cells were transfected by
electroporation using the Amaxa HUVEC Nucleofector kit (Amaxa
GmbH, Koeln, Germany). After transfection with equal amounts of
expression plasmid or empty vector pcDNA3 (Invitrogen, Carlsbad,
CA, USA), HUVECs were treated as indicated.
Flow cytometry
Flow cytometric analysis of E-selectin expression on HUVEC cells
was performed as previously described24 using the FACS flow
cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). Primary
anti-E-selectin (CTB202) mouse mAb (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) and secondary mAbs were used at saturating
concentrations. Isotype-matched primary mAb were used as
negative controls. The mean fluorescence intensity in negative
controls was consistently o10 fluorescence units.
Fluorescent immunocytochemistry
Indirect immunofluorescence staining was performed as before.47
Briefly, cells cultured on chamber slides were fixed with 4%
paraformadehyde. Following donkey serum blocking for 30 min,
cells were incubated with the specific primary and then secondary
antibodies. Finally, cells were stained with 40,6-diamidino-2-
phenylindole to visualize the nuclei. Stained cells were mounted
with Vectashield mounting medium (Vector Laboratories, Burlin-
game, CA, USA) and the extent of stained assessed using a
fluorescence microscope.
Animal studies
Male Sprague–Dawley rats (Harlan Sprague–Dawley, Indianapolis,
IN, USA) with initial weights of 200–250 g were housed in an
approved animal care facility and fed standard chow. On the day of
study, rats were anesthetized, placed on a heated table to keep
constant body temperature, and maintained euvolemic state as
1172 Kidney International (2006) 69, 1166–1174
o r i g i n a l a r t i c l e R Gong et al.: HGF suppresses acute renal inflammation
described before.23 A polyethylene catheter was inserted in the left
carotid artery as an access for drug administration. After a 45-min
equilibration period, HGF (100 mg/kg wt) or an equal volume of
vehicle was administrated as a bolus injection into the left carotid
artery. After 30 min, a bolus injection of rat TNF-a (2mg/kg wt)
(R&D system) or vehicle was given to stimulate the systemic
inflammation. To demonstrate the pro-inflammatory role of E-
selectin, a rabbit anti-E-selectin antibody (Santa Cruz Biotechnol-
ogy) or preimmune IgG was given prior to TNF-a injection. At 4 h
after TNF-a injection, fluorescent-labeled RAM cells (1 104)
resuspended in normal saline were infused via the carotid artery.
Rats were killed before or 30 min after RAM cell infusion and
various organs harvested for further investigation. One portion of
the kidney was immediately frozen for cryostat sectioning. To
quantify the fluorescent RAM cells sequestrated in the kidney,
kidney homogenates with equal amount of protein (100 mg) were
subjected to fluorometric analysis in a fluorescence plate reader as
described above.
Morphologic studies
Indirect immunofluoresent staining of E-selectin was carried out
on methanol/acetone (1:1) fixed frozen cryostat sections
using rabbit polyclonal anti-E-selectin antibody (Santa Cruz
Biotechnology). The Alexa Fluor goat anti-rabbit (Molecular
probes) was used as secondary antibody. As a negative control, the
primary antibody was replaced by nonimmune serum from the
same species; no staining occurred. Frozen sections were double
stained with 40,6-diamidino-2-phenylindole, counterstained with
Evan’s blue and mounted with Vectashield mounting medium.
To visualize fluorescent macrophages sequestrated in the tissue,
cryostat sections were directly fixed and then subjected to counter-
staining.
In quantitative immunofluorescence studies, all sections were
stained and analyzed at the same time to exclude artifacts due to
variable decay of the fluorochrome. Sections were examined at
 400 magnification with a Nikon Microphot-FX fluorescence
microscope equipped with a Spot II digital camera. Captured images
were analyzed with NIH Image (v1.62). The mean fluorescence
intensity was calculated using the arbitrary fluorescence units
obtained in 20 random fields per rat in three rats per group.
Western immunoblot analysis
Rat kidneys were homogenized and HUVEC monolayers were lysed
in RIPA buffer. Protein concentrations were determined using a
bicinchoninic acid protein assay kit (Sigma, St Louis, MO, USA).
Samples with equal amounts of total protein (40–80 mg/ml) were
fractionated by 7.5–10% SDS-polyacrylamide gels under reducing
condition and analyzed by Western immunoblot as described
previously.48 The antibodies against E-selection, Akt, Erk2, p-Stat3,
Stat3, GSK3, and actin were purchased from Sata Cruz Biotechnol-
ogy and those for p-Akt, p-Erk1/2, p-GSK3, and HA were purchased
from Cell Signaling Technology (Beverly, MA, USA).
Statistics
For immunoblot analysis, bands were scanned and the integrated
pixel density was determined using a densitometer and the NIH
image analysis program. All data are expressed as mean7s.d.
Statistical analysis of the data from multiple groups was performed
by ANOVA followed by Student–Newman–Kuels tests. Data from
two groups were compared by Student’s t-test.
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